BioXcel Therapeutics BTAI Institutional Ownership

Ownership Summary

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is held by 39 institutional investors per 13F filings through March 2026.

• They owned 24.1% of outstanding stock in March 2026, down from 29.0% the prior quarter.
• They increased total shares held in BioXcel Therapeutics by 93.58% from the prior quarter, while the number of investors in BTAI increased 21.88% year over year.
• Among the 39 funds, 19 bought more BioXcel Therapeutics shares, 8 sold down, and 12 held their ground.
• In total, institutional investors held 5.68Mn shares in BioXcel Therapeutics as of March 2026, up by 2.75Mn shares quarter on quarter, and up 5.25Mn shares year over year.
• As of March 31, 2026, MILLENNIUM MANAGEMENT LLC held the largest stake in BioXcel Therapeutics with 1.94Mn shares, accounting for 8.22% of total shares outstanding.
• The largest buyers of BioXcel Therapeutics for the quarter ending March 2026 were ARMISTICE CAPITAL, LLC (1.91Mn), OAKTREE CAPITAL MANAGEMENT LP (241.19K), VANGUARD CAPITAL MANAGEMENT LLC (207.34K), MILLENNIUM MANAGEMENT LLC (101.57K), VANGUARD FIDUCIARY TRUST CO (84.92K).
• Leading sellers of BioXcel Therapeutics shares for the quarter ending March 2026 were JONES FINANCIAL COMPANIES LLLP (5.9K), IFP Advisors, Inc (4.36K), GROUP ONE TRADING LLC (3.18K), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (2.88K), Northern Trust Corp (2.06K).
• Business Quant data shows the 10 biggest positions in BioXcel Therapeutics as of March 2026 are held by MILLENNIUM MANAGEMENT LLC (1.94Mn), ARMISTICE CAPITAL, LLC (1.91Mn), OAKTREE CAPITAL MANAGEMENT LP (482.38K), GEODE CAPITAL MANAGEMENT, LLC (230.17K), VANGUARD CAPITAL MANAGEMENT LLC (207.34K), JONES FINANCIAL COMPANIES LLLP (131.79K), Man Group plc (96.47K), State Street Corp (92.12K), FMR LLC (90.3K), VANGUARD FIDUCIARY TRUST CO (84.92K).